HSDT - Financial Snapshot

View on TradingView

📈 Metrics for HSDT

Price $5.24
netCurrentAssetsPerShare $8.48
netCurrentAssetsPerShare = (Current Assets - Total Liabilities) / Shares Outstanding
netTangibleAssetsPerShare $8.61
netTangibleAssetsPerShare = (Total Assets - Intangibles - Total Liabilities) / Shares Outstanding
maxEarningPowerPerShare $-109.75
maxEarningPowerPerShare = (EBITDA / EP_MULTIPLIER) / Shares Outstanding
adjustedEarningPower $-117.35
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
nonCashChargeToMKTCAP 0.2%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
cashValuePerShare $0
cashValuePerShare = (Cash + Short Term Investments - Total Liabilities) / Shares Outstanding
Data as of: Price 11-03-25 16:00 ET, Balance Sheet 2025-06-30, Income Statement 2025-06-30

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non- implantable medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.